Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANITA AFZALI

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1932117074
CMS profile
87052
Location
CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$241,995.10

125 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $198,029.60 100
E.R. Squibb & Sons, L.L.C. $29,190.01 12
Janssen Biotech, Inc. $6,047.09 6
Takeda Pharmaceuticals U.S.A., Inc. $3,626.00 2
Janssen Scientific Affairs, LLC $3,242.40 4
Janssen Global Services, LLC $1,860.00 1

Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANITA AFZALI

NPI 1932117074 · CMS profile ID 87052

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1932117074?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANITA AFZALI, NPI 1932117074, CMS profile ID 87052. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1932117074?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ANITA AFZALI, NPI 1932117074, CMS profile ID 87052. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1932117074?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ANITA AFZALI, NPI 1932117074, CMS profile ID 87052, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1932117074?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

125 matching records · $241,995.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 125 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 125.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $4.6007/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462523 CMS
ABBVIE INC. $127.6007/17/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462525 CMS
ABBVIE INC. $120.6307/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462509 CMS
ABBVIE INC. $6.3207/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462511 CMS
ABBVIE INC. $982.2007/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462513 CMS
ABBVIE INC. $53.5007/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462515 CMS
ABBVIE INC. $62.9007/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462517 CMS
ABBVIE INC. $1.8507/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462519 CMS
ABBVIE INC. $42.5807/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462521 CMS
ABBVIE INC. $6.2007/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462497 CMS
ABBVIE INC. $1.9607/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462499 CMS
ABBVIE INC. $83.6807/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462501 CMS
ABBVIE INC. $46.4907/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462503 CMS
ABBVIE INC. $123.3507/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462505 CMS
ABBVIE INC. $335.5707/15/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462507 CMS
ABBVIE INC. $287.8007/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462493 CMS
ABBVIE INC. $335.5707/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462495 CMS
ABBVIE INC. $9,750.0007/01/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462491 CMS
ABBVIE INC. $1,950.0006/22/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462489 CMS
Janssen Scientific Affairs, LLC $81.4906/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887246163 CMS
Janssen Scientific Affairs, LLC $385.9106/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887246169 CMS
Janssen Scientific Affairs, LLC $1,875.0006/03/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887246157 CMS
ABBVIE INC. $4,550.0005/31/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462487 CMS
Janssen Biotech, Inc. $1,250.0005/24/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886342021 CMS
ABBVIE INC. $1,950.0005/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462485 CMS
Janssen Biotech, Inc. $937.5005/23/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886342015 CMS
Janssen Biotech, Inc. $147.0905/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886342033 CMS
ABBVIE INC. $650.0005/13/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462483 CMS
E.R. Squibb & Sons, L.L.C. $2,860.0005/03/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932927639 CMS
ABBVIE INC. $1,950.0004/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462481 CMS
ABBVIE INC. $1,300.0004/18/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462479 CMS
ABBVIE INC. $3,250.0004/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462473 CMS
ABBVIE INC. $3,250.0004/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462475 CMS
ABBVIE INC. $3,250.0004/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462477 CMS
Janssen Biotech, Inc. $937.5004/13/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886342011 CMS
ABBVIE INC. $4,550.0004/12/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462471 CMS
ABBVIE INC. $226.8004/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462461 CMS
ABBVIE INC. $22.0404/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462463 CMS
ABBVIE INC. $75.1504/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462465 CMS
ABBVIE INC. $3.1204/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462467 CMS
ABBVIE INC. $82.6404/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462469 CMS
ABBVIE INC. $210.1504/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462449 CMS
ABBVIE INC. $124.9104/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462451 CMS
ABBVIE INC. $86.6104/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462453 CMS
ABBVIE INC. $1.1004/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462455 CMS
ABBVIE INC. $110.1804/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462457 CMS
ABBVIE INC. $3.3004/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462459 CMS
ABBVIE INC. $210.1504/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462439 CMS
ABBVIE INC. $168.7404/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462441 CMS
ABBVIE INC. $517.2104/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890462443 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $162,051.97 153
PY2020 $44,454.00 26
PY2021 $69,723.72 45
PY2022 $241,995.10 125
PY2023 $113,606.53 30
PY2024 $99,635.91 63
PY2025 $66,645.64 36

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,930.00 4
PY2025 Principal investigator $112,909.54 10
PY2024 Recipient $7,340.00 3
PY2023 Recipient $330.00 1
PY2023 Principal investigator $1,115.10 3
PY2022 Principal investigator $266,518.17 34
PY2021 Recipient $46,008.90 2
PY2021 Principal investigator $405,855.22 75
PY2020 Principal investigator $359,296.80 86
PY2019 Recipient $483.93 8
PY2019 Principal investigator $475,760.94 81

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,775.25 12/19/2025 Covered Recipient Teaching Hospital
UNIVER.OF CINCINNATI MED CENTER LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223271443
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $8,876.25 11/19/2025 Covered Recipient Teaching Hospital
UNIVER.OF CINCINNATI MED CENTER LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223271437
Recipient PFIZER INC. $330.00 11/17/2025 Covered Recipient Physician ETRASIMOD CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228803872
Recipient PFIZER INC. $330.00 11/17/2025 Covered Recipient Physician ETRASIMOD CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228803957
Recipient PFIZER INC. $940.00 10/27/2025 Covered Recipient Physician ETRASIMOD CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228803879
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/03/2025 Covered Recipient Teaching Hospital
UNIVER.OF CINCINNATI MED CENTER LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223271421
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $8,445.00 10/03/2025 Covered Recipient Teaching Hospital
UNIVER.OF CINCINNATI MED CENTER LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223271423
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $8,995.00 10/03/2025 Covered Recipient Teaching Hospital
UNIVER.OF CINCINNATI MED CENTER LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223271425
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $55,032.75 10/03/2025 Covered Recipient Teaching Hospital
UNIVER.OF CINCINNATI MED CENTER LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223271427
Principal investigator 1 PFIZER INC. $2,654.79 08/27/2025 Non-covered Recipient Entity
University of Cincinnati
A MULTICENTER PROSPECTIVE NONINTERVENTIONAL STUDY OF REALWORLD EFFECTIVENESS OF ETRASIMOD IN PATIENTS WITH ULCERATIVE COLITIS ENDEAVOURUC No dispute reported 06/30/2026 1228827655
Principal investigator 1 PFIZER INC. $20,340.00 08/13/2025 Non-covered Recipient Entity
University of Cincinnati
A MULTICENTER PROSPECTIVE NONINTERVENTIONAL STUDY OF REALWORLD EFFECTIVENESS OF ETRASIMOD IN PATIENTS WITH ULCERATIVE COLITIS ENDEAVOURUC No dispute reported 06/30/2026 1228826965
Principal investigator 1 PFIZER INC. $540.00 08/04/2025 Non-covered Recipient Entity
University of Cincinnati
A MULTICENTER PROSPECTIVE NONINTERVENTIONAL STUDY OF REALWORLD EFFECTIVENESS OF ETRASIMOD IN PATIENTS WITH ULCERATIVE COLITIS ENDEAVOURUC No dispute reported 06/30/2026 1228826972
Recipient PFIZER INC. $330.00 06/02/2025 Covered Recipient Physician ETRASIMOD CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228828338
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $3,550.50 05/21/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223280094